Antibody Drug Manufacturing Solutions | Custom Bioreactors and Buffer/Media Preparation Systems

Solutions

Antibody drugs

The production of antibody drugs relies on precise cell culture and material preparation; given the unique characteristics of protein-based materials, the process demands strict stability and compatibility. Bioreactors and fluid preparation/transfer systems feature customized designs that comply with GMP and EHS standards, enabling stable control of cell culture, compatibility with diverse materials, and seamless integration across the production line—thereby ensuring consistent product quality and stable, large-scale manufacturing.

Explore Products 14.Explore Products

Solutions

Core Services

01

End-to-end customized solutions

We provide customized solutions and core process equipment support spanning the entire antibody production workflow, covering every stage of production.

02

Core Equipment Support Services

Core and auxiliary equipment for the entire antibody production process, including upstream bioreactors, media preparation and feeding systems; downstream intermediate holding tank systems, nanofiltration, UF/DF units, etc.; buffer preparation and storage systems; formulation preparation systems; as well as CIP stations, TCUs, and waste inactivation systems.

03

Supporting services

We provide core technical services including full project lifecycle management, modular equipment integration, automation systems and commissioning, computer system validation, training, and after-sales support.

Solutions

Project Case

Supplied stainless steel piping and tank systems for EPO and long-acting EPO production to one of the largest antibody drug manufacturing bases in China.

$Providing peptide purification and solution preparation systems—including sample loading, fraction collection, low-temperature concentration, and CIP stations—to one of the very few synthetic biology enterprises worldwide with ton-scale annual peptide production capacity.$

Providing peptide purification and solution preparation systems—including sample loading, fraction collection, low-temperature concentration, and CIP stations—to one of the very few synthetic biology enterprises worldwide with ton-scale annual peptide production capacity.

Provided a solution preparation system for diploid cell rabies vaccine bulk to China's first manufacturer of human rabies vaccines; the system includes vaccine bulk processing, buffer preparation, formulation preparation, an inactivation module, a CIP station, and more.

Providing sterile liposome formulation systems to a leading domestic enterprise in nucleic acid drug delivery technology and complex formulations; the scope includes the liposome formulation system, supporting CIP stations, hot water systems, and more.

Provided vaccine bulk formulation systems and CIP systems to the only domestic manufacturer currently selling a domestically produced inactivated Japanese encephalitis vaccine; the scope included formulation systems for bulk Hib, conjugate protein, and Hepatitis A vaccines, as well as CIP stations for the fill-finish stage.

Providing paclitaxel albumin-bound liposome formulation systems to an innovative biotech company focused on photodynamic drugs.

Solutions

Get a Solution

Name *

Email *

Company *

Detailed description